Cidara Therapeutics, Inc. (CDTX)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
-2.94% vs
Rating Accuracy
50.0% (1 of 2*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
17 Hits (39.53% Hit Rate)
FV Avg. Distance
+16.88%
About
CEO
Jeffrey L. Stein
Employees
68
Industry
-
Sector
-
Headquarters
San Diego
Exchange
NASDAQ
Website
http://www.cidara.comSummary Stats
Market Cap
97.4M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 4 analysts
High
$10.00
Average
$7.00
Low
$4.00
Ratings calculated by 4 analysts
Buy
4
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Missed by -$0.01
$0.17 -5.6%
0.18
-0.37
Up 145%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--